Abstract
Transforming growth factor-β1 (TGF-β1) has a biphasic effect on the growth of renal epithelial cells. In transformed cells, TGF-β1 appears to accelerate the proliferation of malignant cells. The diverse cellular functions of TGF-β1 are regulated by three high-affinity serine/threonine kinase receptors, namely TβRI, TβRII and TβRIII. The renal serine protease tissue kallikrein acts on its endogenous protein substrate kininogen to form kinin peptides. The cellular actions of kinins are mediated through B1 and B2 G protein-coupled rhodopsin receptors. Both kinin peptides and TGF-β1 are mitogenic, and therefore may play an important role in carcinogenesis. Experiments were designed to immunolabel tissue kallikrein, TGF-β1, TβRII, TβRIII and kinin receptors using specific antibodies on serial sections of normal kidney and clear-cell renal carcinoma (CCRC) tissue, which included both the tumour and the adjacent renal parenchyma. The essential result was the localisation of tissue kallikrein, kinin B1 and B2 receptors and TGF-β1 primarily on the cell membranes of CCRC cells. In the distal and proximal tubules of the renal parenchyma adjacent to the carcinoma (RPTAC), immunolabelling for tissue kallikrein was reduced, but the expression of kinin B1 and B2 receptors was enhanced. Immunolabelling for TβRII and TβRIII was more pronounced in the proximal tubules of the tissue adjacent to the carcinoma when compared to the normal kidney. The expression of tissue kallikrein, kinin receptors, and TβRII and TβRIII may be relevant to the parenchymal invasion and metastasis of clear-cell renal carcinoma.
References
Akita, K., Okuno, M., Enya, M., Imai, S., Moriwaki, H., Kawada, N., Suzuki, Y., and Kojima, S. (2002). Impaired liver regeneration in mice by lipopolysaccharide via TNF-alpha/kallikrein-mediated activation of latent TGF-β. Gastroentrology123, 352–364.10.1053/gast.2002.34234Search in Google Scholar
Ando, T., Okuda, S., Yanagida, T., and Fujishima, M. (1998). Localization of TGF-β and its receptors in the kidney. Miner. Electrolyte Metab.24, 149–153.10.1159/000057363Search in Google Scholar
Barrack, E.R. (1997). TGF-β in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate31, 61–70.10.1002/(SICI)1097-0045(19970401)31:1<61::AID-PROS10>3.0.CO;2-MSearch in Google Scholar
Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol. Rev.44, 1–80.Search in Google Scholar
Bhoola, K., Ramsaroop, R., Plendl, J., Cassim, B., Dlamini, Z., and Naicker, S. (2001). Kallikrein and kinin receptor expression in inflammation and cancer. Biol. Chem.382, 77–89.10.1515/BC.2001.013Search in Google Scholar
Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer4, 876–890.10.1038/nrc1474Search in Google Scholar
Carroll, V.A. and Binder, B.R. (1999). The role of the plasminogen activation system in cancer. Semin. Thromb. Hemost.12, 211–217.10.1055/s-2007-994920Search in Google Scholar
Clements, J.A. (1994). The human kallikrein gene family: a diversity of expression and function. Mol. Cell. Endocrinol.99, C1–C6.10.1016/0303-7207(94)90138-4Search in Google Scholar
Clements, J., Hooper, J., Dong, Y., and Harvey, T. (2001). The expanded human kallikrein (KLK) gene family: genomic organization, tissue-specific expression and potential functions. Biol. Chem.382, 5–14.10.1515/BC.2001.002Search in Google Scholar
Clements, J.A., Willemsen, N.M., Myers, S.A., and Dong, Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab Sci.41, 265–312.10.1080/10408360490471931Search in Google Scholar
Diamandis, E.P., Yousef, G.M., Luo, L.Y., Magklara, I., and Obiezu, C.V. (2000). The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol. Metab.11, 54–60.10.1016/S1043-2760(99)00225-8Search in Google Scholar
Dlamini, Z., Raidoo, D., and Bhoola, K. (1999). Visualisation of tissue kallikrein and kinin receptors in oesophageal carcinoma. Immunopharmacology43, 303–310.10.1016/S0162-3109(99)00101-0Search in Google Scholar
el-Dahr, S.S., Figueroa, C.D., Gonzalez, C.B., and Müller-Esterl, W. (1997). Ontogeny of bradykinin B2 receptors in the rat kidney: implications for segmental nephron maturation. Kidney Int.51, 739–749.10.1038/ki.1997.105Search in Google Scholar
Figueroa, C.D., MacIver, A.G., Mackenzie, J.C., and Bhoola, K.D. (1988). Localization of immunoreactive kininogen and tissue kallikrein in the human nephron. Histochemistry89, 437–442.10.1007/BF00492599Search in Google Scholar
Govinden, R. and Bhoola, K.D. (2003). Geneology, expression, and cellular function of transforming growth factor-β. Pharmacol. Ther.98, 257–265.10.1016/S0163-7258(03)00035-4Search in Google Scholar
Haaseman, M., Figueroa, C.D., Henderson, L., Grigoriev, S., Abd Alla, S., Gonzalez, C.B., Dunia, I., Hoebeke, J., Jarnagin, K., Cartaud, J., Bhoola, K.D., and Müller-Esterl, W. (1994). Distribution of bradykinin B2 receptors in target cells of kinin action. Visualisation of the receptor proteins in A431 cells, neutrophils and kidney sections. Braz. J. Med. Biol. Res.27, 1739–1756.Search in Google Scholar
Lee-Chen, G.J., Liu, K.P., Lai, Y.C., Juang, H.S., Huang, S.Y., and Lin C.Y. (2004). Significance of the tissue kallikrein promoter and transforming growth factor-β1 polymorphisms with renal progression in children with vesicoureteral reflux. Kidney Int.65, 1467–1472.10.1111/j.1523-1755.2004.00526.xSearch in Google Scholar
MacKay, K., Kondaiah, P., Danielpour, D., Austin, H.A., and Brown, P.D. (1990). Expression of transforming growth factor-β1 and -β2 in rat glomeruli. Kidney Int.38, 1095–1100.10.1038/ki.1990.318Search in Google Scholar
Massague, J. (1990). The transforming growth factor-β family. Annu. Rev. Cell Biol.6, 597–641.10.1146/annurev.cb.06.110190.003121Search in Google Scholar
Massague, J. (1992). Receptors for the TGF-β family. Cell69, 1067–1070.10.1016/0092-8674(92)90627-OSearch in Google Scholar
Massague, J. (1998). TGF-β signal transduction. Annu. Rev. Biochem.67, 753–759.10.1146/annurev.biochem.67.1.753Search in Google Scholar PubMed
Massague, J. and Chen, Y.G. (2000). Controlling TFG-β signaling. Genes Dev.14, 627–644.10.1101/gad.14.6.627Search in Google Scholar
Menke, J.G., Borkowski, J.A., Bierilo, K.K., MacNeil, T., Derrick, A.W., Schneck, K.A., Ransom, R.W., Strader, C.D., Linemeyer, D.L., and Hess, J.F. (1994). Expression cloning of a human B1 bradykinin receptor. J. Biol. Chem.269, 21583–21586.10.1016/S0021-9258(17)31844-6Search in Google Scholar
Naicker, S., Naidoo, S., Ramsaroop, R., Moodley, D., and Bhoola, K. (1999). Tissue kallikrein and kinins in renal disease. Immunopharmacology44, 183–192.10.1016/S0162-3109(99)00089-2Search in Google Scholar
Naidoo, S., Ramsaroop, R.T., Naidoo, Y., and Bhoola, K.D. (1996). Status of B2 receptors in acute renal transplant kidney. Immunopharmacology33, 157–160.10.1016/0162-3109(96)00032-XSearch in Google Scholar
Parada, D., Arciniegas E., Moreira, O., and Trujillo, E. (2004). Transforming growth factor-β2 and -β3 expression in carcinoma of the prostate. Arch. Esp. Urol.57, 9399.Search in Google Scholar
Peek, M., Moran, P., Mendoza, N., Wickramasinghe, D., and Kirchhofer, D. (2002). Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa. J. Biol. Chem.277, 47804–47809.10.1074/jbc.M209778200Search in Google Scholar
Rahn, H.P., Angermann, A., Hektor, T., Kloppinger, M., and Kemme, M. (1992). Expression of human salivary gland kallikrein in insect cells by a baculovirus vector. Agents Actions38 (Suppl.), 66–73.10.1007/978-3-0348-7321-5_9Search in Google Scholar
Ramsaroop, R., Naicker, S., Naicker, T., Naidoo S., and Bhoola, K.D. (1997). Tissue kallikrein in transplant kidney. Immunopharmacology36, 255–261.10.1016/S0162-3109(97)00030-1Search in Google Scholar
Rifkin, D.B. (1997). Cross-talking proteases and matrix in the control of growth factor action. Fibrinolysis Proteolysis11, 3–9.10.1016/S0268-9499(97)80003-3Search in Google Scholar
Rifkin, D.B., Tsuboi, R., and Mignatti, P. (1989). The role of proteases in matrix breakdown during invasion. Am. Rev. Respir. Dis.140, 1112–1113.10.1164/ajrccm/140.4.1112Search in Google Scholar PubMed
Rifkin, D.B., Mazzieri, R., Munger, J.S., Noguera, I., and Song, J. (1999). Proteolytic control of growth factor availability. APMIS107, 80–85.10.1111/j.1699-0463.1999.tb01529.xSearch in Google Scholar PubMed
Roberts, A.B. and Sporn, M.B. (1990). The transforming growth factor-β. In: Handbook of Experimental Pharmacology: Peptide Growth Factors and their Receptors, M.B. Sporn and A.B. Roberts, eds. (Berlin, Germany: Springer-Verlag), pp. 419–472.10.1007/978-3-642-49295-2_8Search in Google Scholar
Roberts, A.B., Anzono, M.A., Wakefield, L.M., Roche, N.S., Stern, D.F., and Sporn, M.B. (1985). Type-β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA82, 119–123.10.1073/pnas.82.1.119Search in Google Scholar PubMed PubMed Central
Roberts, R.A. and Gullick, W.J. (1989). Bradykinin receptor number and sensitivity to ligand stimulation of mitogenesis by expression of mutant ras oncogene. J. Cell Sci.94, 527–535.10.1242/jcs.94.3.527Search in Google Scholar PubMed
Shankland, S.J., Pippin, J., Pichler, R.H., Gordon, K.L., Friedman, S., Gold, L.I., Johnson, R.J., and Couser, W.G. (1996). Differential expression of transforming growth factor-β isoforms and receptors in experimental membranous nephropathy. Kidney Int.50, 116–124.10.1038/ki.1996.294Search in Google Scholar PubMed
Sporn, M.B. and Roberts, A.B. (1990). TGF-β: problems and prospects. Cell Regul.1, 876–882.10.1091/mbc.1.12.875Search in Google Scholar PubMed PubMed Central
Song, Q., Wang, D.Z., Harley, R.A., Chao, L., and Chao, J. (1996). Cellular localisation of low molecular weight kininogen and bradykinin B2 receptor mRNAs in human kidney. Am. J. Physiol.270, F919–F926.Search in Google Scholar
Stravodimos, K., Constantinides, C., Manousakas, T., Pavlaki, C., Pantazopoulos, D., Glannopoulos, A., and Dimopoulos, C. (2000). Immunohistochemical expression of transforming growth factor-β1 and nm-23 H1 antioncogene in prostate cancer: divergent correlation with clinincopathological parameters. Anticancer Res.20, 3823–3828.Search in Google Scholar
Steiner, M.S. and Barrack, E.R. (1992). Transforming growth factor-β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol.6, 15–25.Search in Google Scholar
Vandesande, F. (1983). Immunochemical double staining techniques. In: Immunohistochemistry, A.C. Cuello, ed. (New York, USA: John Wiley and Sons), pp. 257–273.Search in Google Scholar
Yousef, G.M. and Diamandis, E.P. (2000). The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-13. Genomics65, 184–194.10.1006/geno.2000.6159Search in Google Scholar PubMed
© by Walter de Gruyter Berlin New York
